Sol-Gel Technologies SLGL
NASDAQ SLGL
$69.96 -0.14 (-0.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sol-Gel Technologies (SLGL) Cash & Equivalents (2015 - 2026)

Sol-Gel Technologies (SLGL) posted quarterly Cash & Equivalents of $10.1 million for Q1 2026, down 39.99% year-over-year from $16.9 million in Q1 2025, and down 8.13% quarter-over-quarter from $11.0 million in Q4 2025.

Analysis

Sol-Gel Technologies (SLGL) Cash & Equivalents (2015 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has reported Cash & Equivalents for 11 consecutive years, with $10.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash & Equivalents fell 39.99% year-over-year to $10.1 million; the TTM figure through Mar 2026 stood at $10.1 million (down 39.99% YoY), while the FY2025 annual figure was $11.0 million, down 46.61% from the prior year.
  • Cash & Equivalents eased to $10.1 million in Q1 2026 per SLGL's latest filing, from $11.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $21.3 million in Q1 2022 and bottomed at $6.7 million in Q3 2025.
  • Historically, Cash & Equivalents has averaged $13.6 million across 5 years, with a median of $12.7 million in 2024.
  • Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 80.39% — and 2024, when it soared 159.4%.
  • Sol-Gel Technologies' Cash & Equivalents stood at $12.4 million in 2022, then sank by 39.64% to $7.5 million in 2023, then soared by 159.4% to $19.5 million in 2024, then sank by 43.39% to $11.0 million in 2025, then slipped by 8.13% to $10.1 million in 2026.
  • Business Quant data shows SLGL's Cash & Equivalents at $10.1 million in Q1 2026, $11.0 million in Q4 2025, and $6.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1.72 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 815.44 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.71 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 811.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 544.80 Mn
10 Sol-Gel Technologies 194.01 Mn 146.08 Mn - 16.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.66 Mn
Mar 31, 2026 10.14 Mn
Dec 31, 2025 11.03 Mn
Sep 30, 2025 6.71 Mn
Jun 30, 2025 20.67 Mn
Mar 31, 2025 16.89 Mn
Dec 31, 2024 19.49 Mn
Sep 30, 2024 13.42 Mn
Jun 30, 2024 12.71 Mn
Mar 31, 2024 11.21 Mn
Dec 31, 2023 7.51 Mn
Sep 30, 2023 14.14 Mn
Jun 30, 2023 16.79 Mn
Mar 31, 2023 6.81 Mn
Dec 31, 2022 12.45 Mn
Sep 30, 2022 8.50 Mn
Jun 30, 2022 21.24 Mn
Mar 31, 2022 21.25 Mn
Dec 31, 2021 20.09 Mn
Sep 30, 2021 43.35 Mn